Recent progress in genomics has shown that most if not all of the genetic susceptibility to
FCH is polygenic in nature. Future research should include larger cohort studies, with wider …

Familial combined hyperlipidemia (FCHL) constitutes a substantial risk factor for
atherosclerosis since it is observed in about 20% of coronary heart disease (CHD) patients …

Complex disorders are caused by several environmental factors that interact with multiple
genes. These diseases are common at the population level and constitute a major health …

Familial combined hyperlipidemia (FCHL) is one of the most common familial lipoprotein
disorders of the lipoproteins, with a prevalence of 0.5% to 2% in different populations. About …

Ongoing basic research provides a steady growth in our knowledge on the genes that are
involved in FCHL as well as their metabolic function (s). This field of research may be …

Familial combined hyperlipidemia (FCHL) is the most common genetic hyperlipidemia in
man. FCHL is characterized by familial clustering of hyperlipidemia and clinical …

Familial combined hyperlipidemia (FCHL) is the most common genetic dyslipidemia
disorder which is accompanied by increasing of triglyceride and cholesterol. This disorder is …

Background and aims Familial combined hyperlipidemia (FCHL) is one of the most common
inherited lipid phenotypes, characterized by elevated plasma concentrations of …

Familial combined hyperlipidemia (FCHL) is a common dyslipidemia predisposing to
premature coronary heart disease (CHD). The disease is characterized by increased levels …

Coronary heart disease is the leading cause of death in developed countries. This alarming
statistic is partly attributable to lifestyle, and partly due to the genetic factors that make …